Catastrophic Antiphospholipid Syndrome (CAPS) Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Modality (Anticoagulation Therapy , Corticosteroids , Plasma Exchange Therapy , Intravenous Immunoglobulins , Immunosuppressive & Biologic Agents), By Diagnostic Approach (Immunoassay-based Testing , Coagulation-based Assays , Multiplex Biomarker Panels), By Application (Thrombotic Event Management, Multiorgan Failure Mitigation, Obstetric CAPS Management), By End-User (Hospitals & Critical Care Units, Specialty Immunology & Hematology Centers, Academic & Research Institutions) Companies, and Country Forecast, 2021 to 2034
Global Catastrophic Antiphospholipid Syndrome (CAPS) Market size is forecast to increase from $5.47 Billion in 2026 to $12.16 Billion in 2034 at a CAGR of 10.5% between 2026 and 2034.